Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.31B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.17B |
| 3 |
Privia Health
PRVA
|
+$1.13B |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$1.01B |
| 5 |
Sea Limited
SE
|
+$852M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$960M |
| 2 |
Avantor
AVTR
|
+$895M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$760M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$645M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 8.55% |
| 4 | Healthcare | 8.03% |
| 5 | Communication Services | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
CALL
Spotify
SPOT
$98.3B
| $8.4M | ﹤0.01% |
+30,500
| New | +$7.74M |
|
|
KLAQ
2827
DELISTED
KL Acquisition Corp Class A Common Stock
KLAQ
| $8.4M | ﹤0.01% |
866,394
+13,842
| +2% | +$135K |
|
2828
CALL
New Oriental
EDU
$8.96B
| $8.4M | ﹤0.01% |
+102,590
| New | +$12.5M |
|
2829
HUB Group
HUBG
$2.92B
| $8.39M | ﹤0.01% |
254,442
+27,502
| +12% | +$937K |
|
|
DOCU
2830
CALL
DocuSign
DOCU
$11B
| $8.39M | ﹤0.01% |
30,000
| – | – |
|
|
HERA
2831
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
| $8.38M | ﹤0.01% |
+859,574
| New | +$8.4M |
|
|
CORE
2832
DELISTED
Core Mark Holding Co., Inc.
CORE
| $8.37M | ﹤0.01% |
185,886
+109,985
| +145% | +$4.83M |
|
2833
iShares Core MSCI Total International Stock ETF
IXUS
$59.6B
| $8.36M | ﹤0.01% |
114,091
+44,152
| +63% | +$3.23M |
|
|
DCT
2834
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $8.35M | ﹤0.01% |
191,880
-895,490
| -82% | -$36.4M |
|
2835
S&T Bancorp
STBA
$1.86B
| $8.32M | ﹤0.01% |
265,920
-30,718
| -10% | -$1.02M |
|
2836
Invesco CurrencyShares Euro Currency Trust
FXE
$340M
| $8.31M | ﹤0.01% |
75,009
| – | – |
|
2837
MaxLinear
MXL
$6.6B
| $8.31M | ﹤0.01% |
195,550
+72,028
| +58% | +$2.69M |
|
2838
ACM Research
ACMR
$5.7B
| $8.31M | ﹤0.01% |
243,762
-310,788
| -56% | -$8.54M |
|
2839
CALL
Edwards Lifesciences
EW
$51.6B
| $8.29M | ﹤0.01% |
+80,000
| New | +$7.54M |
|
2840
Dana Inc
DAN
$2.97B
| $8.28M | ﹤0.01% |
348,321
-206,108
| -37% | -$5.34M |
|
2841
AdvanSix
ASIX
$546M
| $8.25M | ﹤0.01% |
276,243
+54,415
| +25% | +$1.63M |
|
2842
Replimune Group
REPL
$1B
| $8.25M | ﹤0.01% |
214,698
-214,796
| -50% | -$7.35M |
|
|
DX
2843
Dynex Capital
DX
$3.17B
| $8.24M | ﹤0.01% |
441,645
+379,451
| +610% | +$7.44M |
|
2844
Parsons
PSN
$5.19B
| $8.24M | ﹤0.01% |
209,321
+132,353
| +172% | +$5.44M |
|
|
RCM
2845
DELISTED
R1 RCM Inc. Common Stock
RCM
| $8.23M | ﹤0.01% |
370,105
+206,766
| +127% | +$4.99M |
|
2846
SLM Corp
SLM
$5.24B
| $8.2M | ﹤0.01% |
391,769
+3,579
| +0.9% | +$70.5K |
|
2847
Porch Group
PRCH
$1.87B
| $8.18M | ﹤0.01% |
423,021
+320,111
| +311% | +$5.28M |
|
2848
CALL
Rekor Systems
REKR
$94.9M
| $8.17M | ﹤0.01% |
804,500
+554,500
| +222% | +$8.5M |
|
2849
Atea Pharmaceuticals
AVIR
$376M
| $8.17M | ﹤0.01% |
380,224
+126,036
| +50% | +$3.79M |
|
2850
AnaptysBio
ANAB
$1.63B
| $8.16M | ﹤0.01% |
314,759
-112,293
| -26% | -$2.69M |
|
Similar funds
Goldman Sachs's Q2 2021 Portfolio in Review
As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.
- Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
- Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
- Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
- Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
- Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
- Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
- Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.